Assignee
PYRAMID BIOSCIENCES INC
US·3 granted patents·2 pending applications·3 citations·filing 2018–2023
Top patents by PatentIndex Score
5 records- 0189US11739096B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo [1,5-A]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2022·Granted Aug 29, 2023·1 cites·2 claims
- 0281US11230546B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2018·Granted Jan 25, 2022·2 cites·20 claims
- 0379US12486276B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2023·Granted Dec 2, 2025·0 cites·6 claims
- 0470US2022235055A15-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo [1,5-a]pyrimidine derivatives and related compounds as trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0551US2024092778A1Topical pharmaceutical compositions and methodsPYRAMID BIOSCIENCES INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →